Peter Paul Platenburg at the World Vaccine Congress Europe 2023

Nov 6

Written By Matt Ang

Peter Paul joined the World Vaccine Congress Europe 2023, October 16-19 in Barcelona.
He presented LiteVax’s work on the LVA adjuvant, including preclinical results on the efficacy of the LVA adjuvant in combination with the seasonal influenza vaccine used in the INDIGO project.
The poster gave a unique opportunity to have interesting discussions on the use and performance of the adjuvant.
The World Vaccine Congress brings together global expertise, from basic science to production, including presentations and panel discussions with researchers, small and big pharma as well as organizations such as WHO and PATH. Moreover, it was a good opportunity to meet the INDIGO partners who were also present: Francesca and Alessandro (Vismederi), Peter Paul Platenburg (LiteVax) and Valeria and Elly (AIGHD).

Matt Ang

Jantine van Wijlick presents oral abstract at the European congress on Global Health (ECTMIH2023)

indigo findings presented at 17th vaccine congress